Inpatient and outpatient care
Search documents
Ardent Health Inc (NYSE: ARDT) Downgraded by KeyBanc Following Earnings Miss
Financial Modeling Prep· 2025-11-17 15:06
Core Insights - Ardent Health Inc has been downgraded from Overweight to Sector Weight by KeyBanc due to disappointing earnings results [1][2] - The company reported a quarterly loss of 17 cents per share, missing the analyst consensus estimate of a profit of 41 cents per share [2] - Despite the earnings miss, quarterly sales reached $1.577 billion, exceeding expectations of $1.547 billion [2] Financial Performance - The FY2025 GAAP EPS guidance was reduced from a range of $1.73-$2.01 to $0.85-$1.03 following the earnings miss [2] - Positive trends were noted, including a 5.8% increase in admissions and a 2.9% rise in adjusted admissions [3] - Total surgeries increased by 1.4%, marking the first positive growth this year [3] - Revenue grew by 9% and adjusted EBITDA surged by 46% [3] Stock Performance - The current stock price for ARDT is $9.01, reflecting a decrease of 3.12% or $0.29 [4] - The stock has fluctuated between a low of $8.85 and a high of $9.35 today [4] - Over the past year, the stock reached a high of $17.34 and a low of $8.85, with a market capitalization of approximately $1.29 billion [4]
Ardent Health Inc (NYSE: ARDT) Financial Overview and Analyst Forecast
Financial Modeling Prep· 2025-11-15 06:05
Core Viewpoint - Ardent Health Inc is facing financial challenges despite reporting strong quarterly sales and positive operational trends, leading to a mixed outlook from analysts [2][3][4]. Financial Performance - Ardent Health reported a quarterly loss of 17 cents per share, missing the analyst consensus estimate of a profit of 41 cents per share [3][6]. - The company reduced its FY2025 GAAP EPS guidance from a range of $1.73-$2.01 to $0.85-$1.03 [3]. - Quarterly sales reached $1.577 billion, exceeding expectations of $1.547 billion [4][6]. - Revenue increased by 9%, while adjusted EBITDA saw a significant growth of 46% [5][6]. Market Outlook - Whit Mayo from Leerink Partners set a price target of $16 for ARDT, indicating a potential increase of approximately 77.58% from the current stock price of $9.01 [2][6]. - The stock price has decreased by 3.12% or $0.29 recently, with a market capitalization of approximately $1.29 billion [5]. - Over the past year, ARDT has fluctuated between a high of $17.91 and a low of $8.85 [5]. Operational Trends - Positive operational trends include a 5.8% increase in admissions and a 2.9% rise in adjusted admissions [4]. - Total surgeries increased by 1.4%, indicating growth in service utilization [4].